ALLIANCEBERNSTEIN L.P. - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$346,000
-98.3%
71,500
-96.2%
0.00%
-100.0%
Q4 2019$20,022,000
+19.5%
1,883,518
+17.1%
0.01%
+10.0%
Q3 2019$16,751,000
+2396.4%
1,609,085
+3573.7%
0.01%
Q2 2019$671,000
+19.2%
43,8000.0%0.00%
Q1 2019$563,000
+62.2%
43,800
+20.0%
0.00%
Q4 2018$347,000
-30.3%
36,500
+21.7%
0.00%
Q3 2018$498,000
+9.0%
30,000
+5.3%
0.00%
Q2 2018$457,000
+26.9%
28,500
+21.3%
0.00%
Q1 2018$360,000
+19.6%
23,500
+21.8%
0.00%
Q4 2017$301,000
+40.7%
19,3000.0%0.00%
Q3 2017$214,000
+20.2%
19,3000.0%0.00%
Q2 2017$178,000
+836.8%
19,300
+1384.6%
0.00%
Q1 2015$19,000
-13.6%
1,3000.0%0.00%
Q4 2014$22,000
+37.5%
1,3000.0%0.00%
Q3 2014$16,000
-57.9%
1,300
-50.0%
0.00%
Q2 2014$38,000
+660.0%
2,600
+983.3%
0.00%
Q1 2014$5,000240
+1163.2%
0.00%
Q4 2013$0
-100.0%
19
-99.6%
0.00%
Q3 2013$218,000
+53.5%
4,819
-19.0%
0.00%
Q2 2013$142,0005,9510.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 762,941$7,248,0007.29%
NEXTHERA CAPITAL LP 711,558$6,760,0002.79%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 585,930$4,366,0002.71%
Consonance Capital Management LP 1,155,793$10,980,0000.81%
Pier Capital, LLC 423,667$4,025,0000.80%
KNOTT DAVID M 155,795$1,480,0000.70%
Eventide Asset Management 1,086,400$10,321,0000.46%
Empire Life Investments Inc. 373,863$3,552,0000.32%
Telemetry Investments, L.L.C. 41,588$395,0000.25%
Polar Capital LLP 2,302,666$21,875,0000.23%
View complete list of STEMLINE THERAPEUTICS INC shareholders